Gara Jalqabaatti › Kansarii Ovarii › Washington › Seattle
Qorannoo klinikaalii Kansarii Ovarii Seattle, WA keessatti
Qorannoo 30 Kansarii Ovarii f Seattle fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- Swedish Medical Center-First Hill, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Namoota walitti qabaa jira
- University of Washington, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Namoota walitti qabaa jiraQorannoo ilaalaa
- Fred Hutchinson Cancer Center, Seattle
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Namoota walitti qabaa jiraSadarkaa 1/2
- Seattle Cancer Care Alliance at South Lake Union - G3630, Seattle
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Virginia Mason Hospital and Medical Center /ID# 277259, Seattle
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
Namoota walitti qabaa jiraSadarkaa 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Washington Fred Hutchinson, Seattle
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Namoota walitti qabaa jiraSadarkaa 3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Swedish Cancer Institute, Seattle
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Namoota walitti qabaa jira
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- fi 3 dabalataa
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- fi 4 dabalataa
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Fred Hutchinson Cancer Center, Seattle
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Namoota walitti qabaa jiraSadarkaa 1/2
- Swedish Cancer Institute, Seattle
Clinical Pre-screening Protocol for Ovarian Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Swedish Center for Research and Innovation, Seattle
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- University of Washington - Seattle Cancer Care Alliance, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Namoota walitti qabaa jiraSadarkaa 2
- University of Washington School of Medicine, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutchinson Cancer Center, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutchinson Cancer Center, Seattle
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutchinson Cancer Center, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutchinson Cancer Center, Seattle
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Fred Hutch/University of Washington Cancer Consortium, Seattle
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Namoota walitti qabaa jira
- University of Washington, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Seattle
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- The Swedish Hospital, Seattle
Qorannoo Kansarii Ovarii magaalota biroo keessatti
- Houston, TXQorannoo 89
- New York City, NYQorannoo 69
- Boston, MAQorannoo 61
- Los Angeles, CAQorannoo 50
- Nashville, TNQorannoo 49
- Arlington, VAQorannoo 46
- Philadelphia, PAQorannoo 44
- Columbus, OHQorannoo 39
- St. Louis, MOQorannoo 38
- Chicago, ILQorannoo 36
- San Antonio, TXQorannoo 31
- Cleveland, OHQorannoo 30
Qorannoo biroo Seattle keessatti
- Kansara Qara'a Non-Small CellQorannoo 53
- Saree (Gosoota Hunda)Qorannoo 49
- Kansarii ProstateQorannoo 42
- Leukemia Myeloidii HamaaQorannoo 40
- Saree OljooQorannoo 39
- Kansara MetastatikiiQorannoo 39
- Kansarii ColorectalQorannoo 34
- Dhibee QaraQorannoo 33
- Myeloma Baay’eeQorannoo 22
- Myelodysplastic SyndromesQorannoo 21
- Leukemia Lymphoblasticii HamaaQorannoo 21
- Dukkana BladderQorannoo 21
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.